1.Cytokine Release from Organotypic Human Oral Tissue Following Exposure to Oral Care Product Chemicals
Song-Yi YANG ; Yin-Zhu PIAO ; Kwang-Mahn KIM ; Jae-Sung KWON
Journal of Korean Dental Science 2021;14(2):51-60
Purpose:
Measuring viability of a three-dimensional in vitro organotypic human oral tissue model has been suggested as an alternative test method to the oral mucosa irritation test of oral care products. The aim of this study was to investigate the production of two different cytokines using organotypic human oral tissue model following exposure to chemicals that are commonly used in oral care products.
Materials and Methods:
The organotypic human oral tissues were exposed to ethanol, sodium lauryl sulphate or hydrogen peroxide for 90 minutes. Following exposure, interleukin (IL)-1α and IL-8 productions were assessed and correlated with cell viability testing as well as histology of the organotypic human oral tissues.Result: High levels of IL-8 were released from organotypic human oral tissues in all of the test and control groups without any significant differences between them. In contrast, differences were found in IL-1α release between the test and control groups. Additionally, the trend of IL-1α release corresponded to the phenotypes observed in histological analysis while different trend existed between IL-1α release and cell viability.
Conclusion
The study concluded the non-specific release of IL-8 for the assessment of oral care product chemicals’ toxicity, while potential of measuring IL-1α cytokine level as the possible alternative test method.
2.Treatment of Ankylosing Spondylitis with Modified Jingang Pills
zhu Yong PIAO ; yin Long HAN ; jia Wen ZHAO
Chinese Journal of Information on Traditional Chinese Medicine 2017;24(12):124-126
Ankylosing spondylitis has become a common disease, whether early stage of the low back pain or disability of the late stage of the disease has a serious impact on life quality. There is an urgent need of safe and effective treatment to treat the disease. This article introduced two cases of ankylosing spondylitis treated by modified Jingang Pills, with significant efficacy.